Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cephalosporin Market Growth 2022-2028

  • LP 4938899
  • 122 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cephalosporin will have significant change from previous year. According to our (LP Information) latest study, the global Cephalosporin market size is USD million in 2022 from USD 1350.7 million in 2021, with a change of % between 2021 and 2022. The global Cephalosporin market size will reach USD 1319.6 million in 2028, growing at a CAGR of -0.3% over the analysis period 2022-2028.

The United States Cephalosporin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cephalosporin market, reaching US$ million by the year 2028. As for the Europe Cephalosporin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cephalosporin players cover Union Chempharma, NCPC, Qilu Antibiotics, and Lupin Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cephalosporin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

First Generation Cephalosporin

Second Generation Cephalosporin

Third Generation Cephalosporin

Fourth Generation Cephalosporin

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Oral

Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Union Chempharma

NCPC

Qilu Antibiotics

Lupin Pharmaceuticals

Hospira

Dhanuka Laboratories

Fukang

Dongying Pharmaceutical

Alkem

SALUBRIS

LIVZON

Hetero Drugs

CSPC

TEVA

Orchid Pharma

Taj Pharmaceuticals

Covalent Laboratories

United Laboratories

Aurobindo

Wockhardt

LKPC

HPGC

Huafangpharm

Liaoning Medya Pharmaceutical.

Sichuan Kelun Pharmaceutical

Suzhou Dawnrays Pharmaceutical

Fuan Pharmaceutical

Harbin Pharmaceutical Group

Shandong Ruiying Pioneer Pharmaceutical

Guangdong Liguo Pharmaceutical

Nectar Lifesciences

ACS Dobfar

Novartis

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cephalosporin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cephalosporin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cephalosporin by Country/Region, 2017, 2022 & 2028

2.2 Cephalosporin Segment by Type

2.2.1 First Generation Cephalosporin

2.2.2 Second Generation Cephalosporin

2.2.3 Third Generation Cephalosporin

2.2.4 Fourth Generation Cephalosporin

2.3 Cephalosporin Sales by Type

2.3.1 Global Cephalosporin Sales Market Share by Type (2017-2022)

2.3.2 Global Cephalosporin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cephalosporin Sale Price by Type (2017-2022)

2.4 Cephalosporin Segment by Application

2.4.1 Oral

2.4.2 Injection

2.5 Cephalosporin Sales by Application

2.5.1 Global Cephalosporin Sale Market Share by Application (2017-2022)

2.5.2 Global Cephalosporin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cephalosporin Sale Price by Application (2017-2022)

3 Global Cephalosporin by Company

3.1 Global Cephalosporin Breakdown Data by Company

3.1.1 Global Cephalosporin Annual Sales by Company (2020-2022)

3.1.2 Global Cephalosporin Sales Market Share by Company (2020-2022)

3.2 Global Cephalosporin Annual Revenue by Company (2020-2022)

3.2.1 Global Cephalosporin Revenue by Company (2020-2022)

3.2.2 Global Cephalosporin Revenue Market Share by Company (2020-2022)

3.3 Global Cephalosporin Sale Price by Company

3.4 Key Manufacturers Cephalosporin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cephalosporin Product Location Distribution

3.4.2 Players Cephalosporin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cephalosporin by Geographic Region

4.1 World Historic Cephalosporin Market Size by Geographic Region (2017-2022)

4.1.1 Global Cephalosporin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cephalosporin Annual Revenue by Geographic Region

4.2 World Historic Cephalosporin Market Size by Country/Region (2017-2022)

4.2.1 Global Cephalosporin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cephalosporin Annual Revenue by Country/Region

4.3 Americas Cephalosporin Sales Growth

4.4 APAC Cephalosporin Sales Growth

4.5 Europe Cephalosporin Sales Growth

4.6 Middle East & Africa Cephalosporin Sales Growth

5 Americas

5.1 Americas Cephalosporin Sales by Country

5.1.1 Americas Cephalosporin Sales by Country (2017-2022)

5.1.2 Americas Cephalosporin Revenue by Country (2017-2022)

5.2 Americas Cephalosporin Sales by Type

5.3 Americas Cephalosporin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cephalosporin Sales by Region

6.1.1 APAC Cephalosporin Sales by Region (2017-2022)

6.1.2 APAC Cephalosporin Revenue by Region (2017-2022)

6.2 APAC Cephalosporin Sales by Type

6.3 APAC Cephalosporin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cephalosporin by Country

7.1.1 Europe Cephalosporin Sales by Country (2017-2022)

7.1.2 Europe Cephalosporin Revenue by Country (2017-2022)

7.2 Europe Cephalosporin Sales by Type

7.3 Europe Cephalosporin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cephalosporin by Country

8.1.1 Middle East & Africa Cephalosporin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cephalosporin Revenue by Country (2017-2022)

8.2 Middle East & Africa Cephalosporin Sales by Type

8.3 Middle East & Africa Cephalosporin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cephalosporin

10.3 Manufacturing Process Analysis of Cephalosporin

10.4 Industry Chain Structure of Cephalosporin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cephalosporin Distributors

11.3 Cephalosporin Customer

12 World Forecast Review for Cephalosporin by Geographic Region

12.1 Global Cephalosporin Market Size Forecast by Region

12.1.1 Global Cephalosporin Forecast by Region (2023-2028)

12.1.2 Global Cephalosporin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cephalosporin Forecast by Type

12.7 Global Cephalosporin Forecast by Application

13 Key Players Analysis

13.1 Union Chempharma

13.1.1 Union Chempharma Company Information

13.1.2 Union Chempharma Cephalosporin Product Offered

13.1.3 Union Chempharma Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Union Chempharma Main Business Overview

13.1.5 Union Chempharma Latest Developments

13.2 NCPC

13.2.1 NCPC Company Information

13.2.2 NCPC Cephalosporin Product Offered

13.2.3 NCPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 NCPC Main Business Overview

13.2.5 NCPC Latest Developments

13.3 Qilu Antibiotics

13.3.1 Qilu Antibiotics Company Information

13.3.2 Qilu Antibiotics Cephalosporin Product Offered

13.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Qilu Antibiotics Main Business Overview

13.3.5 Qilu Antibiotics Latest Developments

13.4 Lupin Pharmaceuticals

13.4.1 Lupin Pharmaceuticals Company Information

13.4.2 Lupin Pharmaceuticals Cephalosporin Product Offered

13.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lupin Pharmaceuticals Main Business Overview

13.4.5 Lupin Pharmaceuticals Latest Developments

13.5 Hospira

13.5.1 Hospira Company Information

13.5.2 Hospira Cephalosporin Product Offered

13.5.3 Hospira Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hospira Main Business Overview

13.5.5 Hospira Latest Developments

13.6 Dhanuka Laboratories

13.6.1 Dhanuka Laboratories Company Information

13.6.2 Dhanuka Laboratories Cephalosporin Product Offered

13.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dhanuka Laboratories Main Business Overview

13.6.5 Dhanuka Laboratories Latest Developments

13.7 Fukang

13.7.1 Fukang Company Information

13.7.2 Fukang Cephalosporin Product Offered

13.7.3 Fukang Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Fukang Main Business Overview

13.7.5 Fukang Latest Developments

13.8 Dongying Pharmaceutical

13.8.1 Dongying Pharmaceutical Company Information

13.8.2 Dongying Pharmaceutical Cephalosporin Product Offered

13.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dongying Pharmaceutical Main Business Overview

13.8.5 Dongying Pharmaceutical Latest Developments

13.9 Alkem

13.9.1 Alkem Company Information

13.9.2 Alkem Cephalosporin Product Offered

13.9.3 Alkem Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Alkem Main Business Overview

13.9.5 Alkem Latest Developments

13.10 SALUBRIS

13.10.1 SALUBRIS Company Information

13.10.2 SALUBRIS Cephalosporin Product Offered

13.10.3 SALUBRIS Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 SALUBRIS Main Business Overview

13.10.5 SALUBRIS Latest Developments

13.11 LIVZON

13.11.1 LIVZON Company Information

13.11.2 LIVZON Cephalosporin Product Offered

13.11.3 LIVZON Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 LIVZON Main Business Overview

13.11.5 LIVZON Latest Developments

13.12 Hetero Drugs

13.12.1 Hetero Drugs Company Information

13.12.2 Hetero Drugs Cephalosporin Product Offered

13.12.3 Hetero Drugs Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hetero Drugs Main Business Overview

13.12.5 Hetero Drugs Latest Developments

13.13 CSPC

13.13.1 CSPC Company Information

13.13.2 CSPC Cephalosporin Product Offered

13.13.3 CSPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 CSPC Main Business Overview

13.13.5 CSPC Latest Developments

13.14 TEVA

13.14.1 TEVA Company Information

13.14.2 TEVA Cephalosporin Product Offered

13.14.3 TEVA Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 TEVA Main Business Overview

13.14.5 TEVA Latest Developments

13.15 Orchid Pharma

13.15.1 Orchid Pharma Company Information

13.15.2 Orchid Pharma Cephalosporin Product Offered

13.15.3 Orchid Pharma Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Orchid Pharma Main Business Overview

13.15.5 Orchid Pharma Latest Developments

13.16 Taj Pharmaceuticals

13.16.1 Taj Pharmaceuticals Company Information

13.16.2 Taj Pharmaceuticals Cephalosporin Product Offered

13.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Taj Pharmaceuticals Main Business Overview

13.16.5 Taj Pharmaceuticals Latest Developments

13.17 Covalent Laboratories

13.17.1 Covalent Laboratories Company Information

13.17.2 Covalent Laboratories Cephalosporin Product Offered

13.17.3 Covalent Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Covalent Laboratories Main Business Overview

13.17.5 Covalent Laboratories Latest Developments

13.18 United Laboratories

13.18.1 United Laboratories Company Information

13.18.2 United Laboratories Cephalosporin Product Offered

13.18.3 United Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 United Laboratories Main Business Overview

13.18.5 United Laboratories Latest Developments

13.19 Aurobindo

13.19.1 Aurobindo Company Information

13.19.2 Aurobindo Cephalosporin Product Offered

13.19.3 Aurobindo Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Aurobindo Main Business Overview

13.19.5 Aurobindo Latest Developments

13.20 Wockhardt

13.20.1 Wockhardt Company Information

13.20.2 Wockhardt Cephalosporin Product Offered

13.20.3 Wockhardt Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Wockhardt Main Business Overview

13.20.5 Wockhardt Latest Developments

13.21 LKPC

13.21.1 LKPC Company Information

13.21.2 LKPC Cephalosporin Product Offered

13.21.3 LKPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 LKPC Main Business Overview

13.21.5 LKPC Latest Developments

13.22 HPGC

13.22.1 HPGC Company Information

13.22.2 HPGC Cephalosporin Product Offered

13.22.3 HPGC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 HPGC Main Business Overview

13.22.5 HPGC Latest Developments

13.23 Huafangpharm

13.23.1 Huafangpharm Company Information

13.23.2 Huafangpharm Cephalosporin Product Offered

13.23.3 Huafangpharm Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Huafangpharm Main Business Overview

13.23.5 Huafangpharm Latest Developments

13.24 Liaoning Medya Pharmaceutical.

13.24.1 Liaoning Medya Pharmaceutical. Company Information

13.24.2 Liaoning Medya Pharmaceutical. Cephalosporin Product Offered

13.24.3 Liaoning Medya Pharmaceutical. Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Liaoning Medya Pharmaceutical. Main Business Overview

13.24.5 Liaoning Medya Pharmaceutical. Latest Developments

13.25 Sichuan Kelun Pharmaceutical

13.25.1 Sichuan Kelun Pharmaceutical Company Information

13.25.2 Sichuan Kelun Pharmaceutical Cephalosporin Product Offered

13.25.3 Sichuan Kelun Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Sichuan Kelun Pharmaceutical Main Business Overview

13.25.5 Sichuan Kelun Pharmaceutical Latest Developments

13.26 Suzhou Dawnrays Pharmaceutical

13.26.1 Suzhou Dawnrays Pharmaceutical Company Information

13.26.2 Suzhou Dawnrays Pharmaceutical Cephalosporin Product Offered

13.26.3 Suzhou Dawnrays Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Suzhou Dawnrays Pharmaceutical Main Business Overview

13.26.5 Suzhou Dawnrays Pharmaceutical Latest Developments

13.27 Fuan Pharmaceutical

13.27.1 Fuan Pharmaceutical Company Information

13.27.2 Fuan Pharmaceutical Cephalosporin Product Offered

13.27.3 Fuan Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Fuan Pharmaceutical Main Business Overview

13.27.5 Fuan Pharmaceutical Latest Developments

13.28 Harbin Pharmaceutical Group

13.28.1 Harbin Pharmaceutical Group Company Information

13.28.2 Harbin Pharmaceutical Group Cephalosporin Product Offered

13.28.3 Harbin Pharmaceutical Group Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Harbin Pharmaceutical Group Main Business Overview

13.28.5 Harbin Pharmaceutical Group Latest Developments

13.29 Shandong Ruiying Pioneer Pharmaceutical

13.29.1 Shandong Ruiying Pioneer Pharmaceutical Company Information

13.29.2 Shandong Ruiying Pioneer Pharmaceutical Cephalosporin Product Offered

13.29.3 Shandong Ruiying Pioneer Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 Shandong Ruiying Pioneer Pharmaceutical Main Business Overview

13.29.5 Shandong Ruiying Pioneer Pharmaceutical Latest Developments

13.30 Guangdong Liguo Pharmaceutical

13.30.1 Guangdong Liguo Pharmaceutical Company Information

13.30.2 Guangdong Liguo Pharmaceutical Cephalosporin Product Offered

13.30.3 Guangdong Liguo Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2022)

13.30.4 Guangdong Liguo Pharmaceutical Main Business Overview

13.30.5 Guangdong Liguo Pharmaceutical Latest Developments

13.31 Nectar Lifesciences

13.32 ACS Dobfar

13.33 Novartis

14 Research Findings and Conclusion

List of Tables

Table 1. Cephalosporin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cephalosporin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of First Generation Cephalosporin

Table 4. Major Players of Second Generation Cephalosporin

Table 5. Major Players of Third Generation Cephalosporin

Table 6. Major Players of Fourth Generation Cephalosporin

Table 7. Global Cephalosporin Sales by Type (2017-2022) & (MT)

Table 8. Global Cephalosporin Sales Market Share by Type (2017-2022)

Table 9. Global Cephalosporin Revenue by Type (2017-2022) & ($ million)

Table 10. Global Cephalosporin Revenue Market Share by Type (2017-2022)

Table 11. Global Cephalosporin Sale Price by Type (2017-2022) & (USD/Kg)

Table 12. Global Cephalosporin Sales by Application (2017-2022) & (MT)

Table 13. Global Cephalosporin Sales Market Share by Application (2017-2022)

Table 14. Global Cephalosporin Revenue by Application (2017-2022)

Table 15. Global Cephalosporin Revenue Market Share by Application (2017-2022)

Table 16. Global Cephalosporin Sale Price by Application (2017-2022) & (USD/Kg)

Table 17. Global Cephalosporin Sales by Company (2020-2022) & (MT)

Table 18. Global Cephalosporin Sales Market Share by Company (2020-2022)

Table 19. Global Cephalosporin Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Cephalosporin Revenue Market Share by Company (2020-2022)

Table 21. Global Cephalosporin Sale Price by Company (2020-2022) & (USD/Kg)

Table 22. Key Manufacturers Cephalosporin Producing Area Distribution and Sales Area

Table 23. Players Cephalosporin Products Offered

Table 24. Cephalosporin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Cephalosporin Sales by Geographic Region (2017-2022) & (MT)

Table 28. Global Cephalosporin Sales Market Share Geographic Region (2017-2022)

Table 29. Global Cephalosporin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Cephalosporin Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Cephalosporin Sales by Country/Region (2017-2022) & (MT)

Table 32. Global Cephalosporin Sales Market Share by Country/Region (2017-2022)

Table 33. Global Cephalosporin Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Cephalosporin Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Cephalosporin Sales by Country (2017-2022) & (MT)

Table 36. Americas Cephalosporin Sales Market Share by Country (2017-2022)

Table 37. Americas Cephalosporin Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Cephalosporin Revenue Market Share by Country (2017-2022)

Table 39. Americas Cephalosporin Sales by Type (2017-2022) & (MT)

Table 40. Americas Cephalosporin Sales Market Share by Type (2017-2022)

Table 41. Americas Cephalosporin Sales by Application (2017-2022) & (MT)

Table 42. Americas Cephalosporin Sales Market Share by Application (2017-2022)

Table 43. APAC Cephalosporin Sales by Region (2017-2022) & (MT)

Table 44. APAC Cephalosporin Sales Market Share by Region (2017-2022)

Table 45. APAC Cephalosporin Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Cephalosporin Revenue Market Share by Region (2017-2022)

Table 47. APAC Cephalosporin Sales by Type (2017-2022) & (MT)

Table 48. APAC Cephalosporin Sales Market Share by Type (2017-2022)

Table 49. APAC Cephalosporin Sales by Application (2017-2022) & (MT)

Table 50. APAC Cephalosporin Sales Market Share by Application (2017-2022)

Table 51. Europe Cephalosporin Sales by Country (2017-2022) & (MT)

Table 52. Europe Cephalosporin Sales Market Share by Country (2017-2022)

Table 53. Europe Cephalosporin Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Cephalosporin Revenue Market Share by Country (2017-2022)

Table 55. Europe Cephalosporin Sales by Type (2017-2022) & (MT)

Table 56. Europe Cephalosporin Sales Market Share by Type (2017-2022)

Table 57. Europe Cephalosporin Sales by Application (2017-2022) & (MT)

Table 58. Europe Cephalosporin Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Cephalosporin Sales by Country (2017-2022) & (MT)

Table 60. Middle East & Africa Cephalosporin Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cephalosporin Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Cephalosporin Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Cephalosporin Sales by Type (2017-2022) & (MT)

Table 64. Middle East & Africa Cephalosporin Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Cephalosporin Sales by Application (2017-2022) & (MT)

Table 66. Middle East & Africa Cephalosporin Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Cephalosporin

Table 68. Key Market Challenges & Risks of Cephalosporin

Table 69. Key Industry Trends of Cephalosporin

Table 70. Cephalosporin Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Cephalosporin Distributors List

Table 73. Cephalosporin Customer List

Table 74. Global Cephalosporin Sales Forecast by Region (2023-2028) & (MT)

Table 75. Global Cephalosporin Sales Market Forecast by Region

Table 76. Global Cephalosporin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Cephalosporin Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Cephalosporin Sales Forecast by Country (2023-2028) & (MT)

Table 79. Americas Cephalosporin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Cephalosporin Sales Forecast by Region (2023-2028) & (MT)

Table 81. APAC Cephalosporin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Cephalosporin Sales Forecast by Country (2023-2028) & (MT)

Table 83. Europe Cephalosporin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Cephalosporin Sales Forecast by Country (2023-2028) & (MT)

Table 85. Middle East & Africa Cephalosporin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Cephalosporin Sales Forecast by Type (2023-2028) & (MT)

Table 87. Global Cephalosporin Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Cephalosporin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Cephalosporin Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Cephalosporin Sales Forecast by Application (2023-2028) & (MT)

Table 91. Global Cephalosporin Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Cephalosporin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Cephalosporin Revenue Market Share Forecast by Application (2023-2028)

Table 94. Union Chempharma Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 95. Union Chempharma Cephalosporin Product Offered

Table 96. Union Chempharma Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 97. Union Chempharma Main Business

Table 98. Union Chempharma Latest Developments

Table 99. NCPC Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 100. NCPC Cephalosporin Product Offered

Table 101. NCPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 102. NCPC Main Business

Table 103. NCPC Latest Developments

Table 104. Qilu Antibiotics Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 105. Qilu Antibiotics Cephalosporin Product Offered

Table 106. Qilu Antibiotics Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 107. Qilu Antibiotics Main Business

Table 108. Qilu Antibiotics Latest Developments

Table 109. Lupin Pharmaceuticals Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 110. Lupin Pharmaceuticals Cephalosporin Product Offered

Table 111. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 112. Lupin Pharmaceuticals Main Business

Table 113. Lupin Pharmaceuticals Latest Developments

Table 114. Hospira Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 115. Hospira Cephalosporin Product Offered

Table 116. Hospira Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 117. Hospira Main Business

Table 118. Hospira Latest Developments

Table 119. Dhanuka Laboratories Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 120. Dhanuka Laboratories Cephalosporin Product Offered

Table 121. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 122. Dhanuka Laboratories Main Business

Table 123. Dhanuka Laboratories Latest Developments

Table 124. Fukang Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 125. Fukang Cephalosporin Product Offered

Table 126. Fukang Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 127. Fukang Main Business

Table 128. Fukang Latest Developments

Table 129. Dongying Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 130. Dongying Pharmaceutical Cephalosporin Product Offered

Table 131. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 132. Dongying Pharmaceutical Main Business

Table 133. Dongying Pharmaceutical Latest Developments

Table 134. Alkem Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 135. Alkem Cephalosporin Product Offered

Table 136. Alkem Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 137. Alkem Main Business

Table 138. Alkem Latest Developments

Table 139. SALUBRIS Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 140. SALUBRIS Cephalosporin Product Offered

Table 141. SALUBRIS Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 142. SALUBRIS Main Business

Table 143. SALUBRIS Latest Developments

Table 144. LIVZON Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 145. LIVZON Cephalosporin Product Offered

Table 146. LIVZON Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 147. LIVZON Main Business

Table 148. LIVZON Latest Developments

Table 149. Hetero Drugs Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 150. Hetero Drugs Cephalosporin Product Offered

Table 151. Hetero Drugs Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 152. Hetero Drugs Main Business

Table 153. Hetero Drugs Latest Developments

Table 154. CSPC Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 155. CSPC Cephalosporin Product Offered

Table 156. CSPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 157. CSPC Main Business

Table 158. CSPC Latest Developments

Table 159. TEVA Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 160. TEVA Cephalosporin Product Offered

Table 161. TEVA Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 162. TEVA Main Business

Table 163. TEVA Latest Developments

Table 164. Orchid Pharma Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 165. Orchid Pharma Cephalosporin Product Offered

Table 166. Orchid Pharma Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 167. Orchid Pharma Main Business

Table 168. Orchid Pharma Latest Developments

Table 169. Taj Pharmaceuticals Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 170. Taj Pharmaceuticals Cephalosporin Product Offered

Table 171. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 172. Taj Pharmaceuticals Main Business

Table 173. Taj Pharmaceuticals Latest Developments

Table 174. Covalent Laboratories Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 175. Covalent Laboratories Cephalosporin Product Offered

Table 176. Covalent Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 177. Covalent Laboratories Main Business

Table 178. Covalent Laboratories Latest Developments

Table 179. United Laboratories Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 180. United Laboratories Cephalosporin Product Offered

Table 181. United Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 182. United Laboratories Main Business

Table 183. United Laboratories Latest Developments

Table 184. Aurobindo Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 185. Aurobindo Cephalosporin Product Offered

Table 186. Aurobindo Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 187. Aurobindo Main Business

Table 188. Aurobindo Latest Developments

Table 189. Wockhardt Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 190. Wockhardt Cephalosporin Product Offered

Table 191. Wockhardt Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 192. Wockhardt Main Business

Table 193. Wockhardt Latest Developments

Table 194. LKPC Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 195. LKPC Cephalosporin Product Offered

Table 196. LKPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 197. LKPC Main Business

Table 198. LKPC Latest Developments

Table 199. HPGC Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 200. HPGC Cephalosporin Product Offered

Table 201. HPGC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 202. HPGC Main Business

Table 203. HPGC Latest Developments

Table 204. Huafangpharm Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 205. Huafangpharm Cephalosporin Product Offered

Table 206. Huafangpharm Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 207. Huafangpharm Main Business

Table 208. Huafangpharm Latest Developments

Table 209. Liaoning Medya Pharmaceutical. Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 210. Liaoning Medya Pharmaceutical. Cephalosporin Product Offered

Table 211. Liaoning Medya Pharmaceutical. Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 212. Liaoning Medya Pharmaceutical. Main Business

Table 213. Liaoning Medya Pharmaceutical. Latest Developments

Table 214. Sichuan Kelun Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 215. Sichuan Kelun Pharmaceutical Cephalosporin Product Offered

Table 216. Sichuan Kelun Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 217. Sichuan Kelun Pharmaceutical Main Business

Table 218. Sichuan Kelun Pharmaceutical Latest Developments

Table 219. Suzhou Dawnrays Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 220. Suzhou Dawnrays Pharmaceutical Cephalosporin Product Offered

Table 221. Suzhou Dawnrays Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 222. Suzhou Dawnrays Pharmaceutical Main Business

Table 223. Suzhou Dawnrays Pharmaceutical Latest Developments

Table 224. Fuan Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 225. Fuan Pharmaceutical Cephalosporin Product Offered

Table 226. Fuan Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 227. Fuan Pharmaceutical Main Business

Table 228. Fuan Pharmaceutical Latest Developments

Table 229. Harbin Pharmaceutical Group Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 230. Harbin Pharmaceutical Group Cephalosporin Product Offered

Table 231. Harbin Pharmaceutical Group Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 232. Harbin Pharmaceutical Group Main Business

Table 233. Harbin Pharmaceutical Group Latest Developments

Table 234. Shandong Ruiying Pioneer Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 235. Shandong Ruiying Pioneer Pharmaceutical Cephalosporin Product Offered

Table 236. Shandong Ruiying Pioneer Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 237. Shandong Ruiying Pioneer Pharmaceutical Main Business

Table 238. Shandong Ruiying Pioneer Pharmaceutical Latest Developments

Table 239. Guangdong Liguo Pharmaceutical Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 240. Guangdong Liguo Pharmaceutical Cephalosporin Product Offered

Table 241. Guangdong Liguo Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 242. Guangdong Liguo Pharmaceutical Main Business

Table 243. Guangdong Liguo Pharmaceutical Latest Developments

Table 244. Nectar Lifesciences Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 245. Nectar Lifesciences Cephalosporin Product Offered

Table 246. Nectar Lifesciences Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 247. Nectar Lifesciences Main Business

Table 248. Nectar Lifesciences Latest Developments

Table 249. ACS Dobfar Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 250. ACS Dobfar Cephalosporin Product Offered

Table 251. ACS Dobfar Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 252. ACS Dobfar Main Business

Table 253. ACS Dobfar Latest Developments

Table 254. Novartis Basic Information, Cephalosporin Manufacturing Base, Sales Area and Its Competitors

Table 255. Novartis Cephalosporin Product Offered

Table 256. Novartis Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 257. Novartis Main Business

Table 258. Novartis Latest Developments

List of Figures

Figure 1. Picture of Cephalosporin

Figure 2. Cephalosporin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cephalosporin Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Cephalosporin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cephalosporin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of First Generation Cephalosporin

Figure 10. Product Picture of Second Generation Cephalosporin

Figure 11. Product Picture of Third Generation Cephalosporin

Figure 12. Product Picture of Fourth Generation Cephalosporin

Figure 13. Global Cephalosporin Sales Market Share by Type in 2021

Figure 14. Global Cephalosporin Revenue Market Share by Type (2017-2022)

Figure 15. Cephalosporin Consumed in Oral

Figure 16. Global Cephalosporin Market: Oral (2017-2022) & (MT)

Figure 17. Cephalosporin Consumed in Injection

Figure 18. Global Cephalosporin Market: Injection (2017-2022) & (MT)

Figure 19. Global Cephalosporin Sales Market Share by Application (2017-2022)

Figure 20. Global Cephalosporin Revenue Market Share by Application in 2021

Figure 21. Cephalosporin Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Cephalosporin Revenue Market Share by Company in 2021

Figure 23. Global Cephalosporin Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Cephalosporin Revenue Market Share by Geographic Region in 2021

Figure 25. Global Cephalosporin Sales Market Share by Region (2017-2022)

Figure 26. Global Cephalosporin Revenue Market Share by Country/Region in 2021

Figure 27. Americas Cephalosporin Sales 2017-2022 (MT)

Figure 28. Americas Cephalosporin Revenue 2017-2022 ($ Millions)

Figure 29. APAC Cephalosporin Sales 2017-2022 (MT)

Figure 30. APAC Cephalosporin Revenue 2017-2022 ($ Millions)

Figure 31. Europe Cephalosporin Sales 2017-2022 (MT)

Figure 32. Europe Cephalosporin Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Cephalosporin Sales 2017-2022 (MT)

Figure 34. Middle East & Africa Cephalosporin Revenue 2017-2022 ($ Millions)

Figure 35. Americas Cephalosporin Sales Market Share by Country in 2021

Figure 36. Americas Cephalosporin Revenue Market Share by Country in 2021

Figure 37. United States Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Cephalosporin Sales Market Share by Region in 2021

Figure 42. APAC Cephalosporin Revenue Market Share by Regions in 2021

Figure 43. China Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Cephalosporin Sales Market Share by Country in 2021

Figure 50. Europe Cephalosporin Revenue Market Share by Country in 2021

Figure 51. Germany Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Cephalosporin Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Cephalosporin Revenue Market Share by Country in 2021

Figure 58. Egypt Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Cephalosporin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Cephalosporin in 2021

Figure 64. Manufacturing Process Analysis of Cephalosporin

Figure 65. Industry Chain Structure of Cephalosporin

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390